LIZBETH HERRERA: Open Payments
NPI 1043867914 · EL DORADO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 25 payments from 6 companies in 2025. Trend: 2023 $185 · 2024 $257 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $240 |
| ABBVIE INC. | 9 | $188 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
Products named: CAPLYTA, VRAYLAR, Auvelity, REXULTI, INGREZZA, Qelbree.
Industry payments across AR — which companies pay providers there.
